Abstract
Trial finds that enoxaparin may be the preferred drug for initiating anticoagulation in atrial fibrillation*1Abstracted from: Stellbrink C, Nixdorff U, Hofmann T, et al. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial. Circulation 2004; 109: 997-1003.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have